Pacira Pharmaceuticals, Inc. | Business Contracts

Amendment No. 1 to Pacira BioSciences, Inc. Deferred Compensation Plan (Filed With SEC on February 28, 2023)

Amended and Restated 2014 Employee Stock Purchase Plan (Filed With SEC on June 10, 2022)

Side Letter to the Manufacturing and Supply Agreement between Flexion Therapeutics, Inc. and Patheon UK Limited, dated as of April 8, 2020 (Filed With SEC on February 28, 2022)

Agreement and Plan of Merger, dated as of October 11, 2021, by and among Flexion Therapeutics, Inc., Pacira BioSciences, Inc. and Oyster Acquisition Company Inc (Filed With SEC on October 12, 2021)

Form of Tender and Support Agreement, dated as of October 11, 2021 (Filed With SEC on October 12, 2021)

Executive Employment Agreement, dated May 4, 2020, between the Registrant and Jonathan Slonin (Filed With SEC on May 4, 2022)

Technical Transfer and Service Agreement dated July 31, 2015, between Flexion Therapeutics, Inc. and Patheon UK Limited, as amended to date (Filed With SEC on February 28, 2022)

Manufacturing and Supply Agreement dated July 31, 2015, between Flexion Therapeutics, Inc. and Patheon UK Limited, as amended to date (Filed With SEC on February 28, 2022)

Form of Nonstatutory Stock Option Agreement (Non-Employee Directors) under the Amended and Restated 2011 Stock Incentive Plan for grants made on or after February 1, 2022 (Filed With SEC on February 28, 2022)

Form of Nonstatutory Stock Option Agreement (Employees) under the Amended and Restated 2011 Stock Incentive Plan for grants made on or after February 1, 2022 (Filed With SEC on February 28, 2022)

First Supplemental Indenture, dated as of November 19, 2021, by and between Flexion Therapeutics, Inc. and Wells Fargo Bank, National Association, as trustee (Filed With SEC on February 28, 2022)

Indenture (including form of 3.375% Convertible Senior Notes due 2024), dated as of May 2, 2017, by and between Flexion Therapeutics, Inc. and Wells Fargo Bank, National... (Filed With SEC on February 28, 2022)

Contingent Value Right Agreement, dated as of November 19, 2021, by and between Pacira BioSciences, Inc. and American Stock Transfer & Trust Company, LLC (Filed With SEC on November 19, 2021)

Amended and Restated 2011 Stock Incentive Plan (Filed With SEC on June 11, 2021)

Executive Employment Agreement, dated June 1, 2020, between the Registrant and Donald Manning (Filed With SEC on May 4, 2021)

Pacira BioSciences, Inc. Long-Term Incentive Plan (Filed With SEC on December 7, 2020)

Indenture, dated as of July 10, 2020, by and between the Company and Wells Fargo Bank, National Association (Filed With SEC on July 10, 2020)

Pacira BioSciences, Inc. Deferred Compensation Plan (Filed With SEC on June 11, 2020)

Fourth through Eleventh Amendments to Commercial Outsourcing Services Agreement, between the Registrant and Integrated Commercialization Solutions, Inc (Filed With SEC on May 7, 2020)

Executive Employment Agreement, dated April 24, 2017, between the Registrant and Roy Winston (Filed With SEC on May 7, 2020)

Executive Employment Agreement, dated June 19, 2019, between the Registrant and Max Reinhardt (Filed With SEC on May 7, 2020)

Description of Securities (Filed With SEC on February 21, 2020)

Amended and Restated 2011 Stock Incentive Plan (Filed With SEC on August 8, 2019)

Amended and Restated 2011 Stock Incentive Plan (Filed With SEC on June 7, 2019)

Specimen Certificate Evidencing Shares of Common Stock (Filed With SEC on May 2, 2019)

Executive Employment Agreement, dated May 29, 2017, between the Registrant and Dennis McLoughlin (Filed With SEC on May 2, 2019)

Agreement and Plan of Merger, dated March 4, 2019, by and among Pacira Pharmaceuticals, Inc., PS Merger, Inc., MyoScience, Inc., and Fortis Advisors LLC, a Delaware limited... (Filed With SEC on March 5, 2019)

Second Amendment to Co-Promotion Agreement, dated December 21, 2018, between the Registrant and DePuy Synthes Sales, Inc (Filed With SEC on February 28, 2019)

Pacira Pharmaceuticals, Inc. (28)